Sanctura
trospium chloride
Pharmacologic class: Anticholinergic, antimuscarinic
Therapeutic class: Renal and genitourinary agent, antispasmodic
Pregnancy risk category C
Action
Antagonizes effects of acetylcholine on muscarinic receptors in cholinergically innervated organs, reducing bladder smooth muscle tone
Availability
Capsules (extended-release): 60 mg
Tablets: 20 mg
Indications and dosages
➣ Overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency
Adults: 20 mg P.O. twice daily 1 hour before meals or on empty stomach, or 1 60-mg capsule daily in morning with water at least 1 hour before a meal
Dosage adjustment
• Severe renal impairment
• Patients age 75 and older
Contraindications
• Hypersensitivity to drug or its components
• Preexisting or risk of urinary or gastric retention or uncontrolled angle-closure glaucoma
Precautions
Use cautiously in:
• moderate renal impairment, moderate to severe hepatic impairment, decreased GI motility, controlled angle-closure glaucoma, clinically significant bladder outflow obstruction or GI obstructive disorders
• patients at risk for heat prostration
• elderly patients
• pregnant or breastfeeding patients
• children (safety and efficacy not established).
Administration
• Give at least 1 hour before meals or on empty stomach.
Adverse reactions
CNS: headache, fatigue, syncope, hallucinations, delirium, dizziness, drowsiness
CV: tachycardia, chest pain
EENT: dry eyes, blurred vision, dry throat
GI: vomiting, constipation (new-onset or aggravated), upper abdominal pain, dyspepsia, flatulence, abdominal distention, dry mouth
GU: urinary retention
Skin: dry skin
Other: altered taste, heat prostration, angioedema
Interactions
Drug-drug. Anticholinergics: additive anticholinergic effects
Digoxin, metformin, morphine, pancuronium, procainamide, tenofovir, vancomycin: increased blood levels of both drugs
Drug-behaviors. Alcohol use: increased risk of drowsiness
Patient monitoring
• Monitor renal and hepatic function tests.
• Monitor patient for decreased GI motility and urinary retention.
See If patient has controlled angle-closure glaucoma, stay alert for severe eye pain accompanied by nausea, rainbows around lights, red eye, and blurred vision. Be prepared to treat immediately, as appropriate.
See Be aware that angioedema associated with life-threatening upper airway swelling may occur. If involvement of the tongue, hypopharynx, or larynx occurs, promptly discontinue drug and provide appropriate treatment.
Patient teaching
• Instruct patient to take tablet 1 hour before meals on an empty stomach or to take capsule in morning with water at least 1 hour before a meal.
• Instruct patient not to consume alcohol within 2 hours of taking extended-release capsule.
• Advise patient to consult prescriber before taking over-the-counter products such as antihistamines because these may increase risk of side effects.
• Inform patient that drug increases risk of heat prostration; describe symptoms and advise him to seek prompt medical attention if these occur.
• Caution patient to avoid driving and other hazardous activities until drug effects are known.
• Advise patient to avoid alcohol use.
• As appropriate, review all other significant adverse reactions and interactions, especially those related to the drugs and behaviors mentioned above.
v
trospium
(tros-pee-yum) trospium,Sanctura
(trade name),Sanctura XR
(trade name),Trosec
(trade name)Classification
Therapeutic: urinary tract antispasmodicsPharmacologic: antimuscarinics
Indications
Action
Therapeutic effects
Pharmacokinetics
Time/action profile (anticholinergic effects)
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO | unknown | 5–6 hr | 24 hr |
Contraindications/Precautions
Adverse Reactions/Side Effects
Central nervous system
- headache (most frequent)
- confusion
- dizziness
- drowsiness
- fatigue
- hallucinations
Ear, Eye, Nose, Throat
- blurred vision
Gastrointestinal
- constipation (most frequent)
- dry mouth (most frequent)
- dyspepsia
Genitourinary
- urinary retention
- urinary tract infection
Miscellaneous
- angioedema (life-threatening)
- fever
- heat stroke
Interactions
Drug-Drug interaction
May interact with other drugs that compete for tubular secretion.Metformin may ↓ levels.↑ risk of anticholinergic effects with other drugs having anticholinergic properties.Route/Dosage
Renal Impairment
Oral (Adults) CCr <30 mL/min—20 mg once daily at bedtime.Availability (generic available)
Nursing implications
Nursing assessment
- Monitor voiding pattern and intake and output ratios.
Potential Nursing Diagnoses
Impaired urinary elimination (Indications)Implementation
- Oral: Administer 1 hr prior to meals or on an empty stomach.
Patient/Family Teaching
- Instruct patient to take as directed. If a dose is skipped, take next dose 1 hr prior to next meal.
- May cause drowsiness, dizziness, and blurred vision. Caution patient to avoid driving and other activities requiring alertness until response to medication is known. Advise patient to avoid alcohol; may increase drowsiness.
- Advise patient to notify health care professional immediately of signs and symptoms of angioedema (edema of the tongue or laryngopharynx, difficulty breathing) occur.
- Caution patient that heat prostration (fever and heat stroke due to decreased sweating) may occur when trospium is taken in a hot environment.
- Instruct patient to notify health care professional of all Rx or OTC medications, vitamins, or herbal products being taken and consult health care professional before taking any new medications.
- Advise female patient to notify health care professional if pregnancy is planned or suspected, or if breast feeding.
Evaluation/Desired Outcomes
- Increased bladder capacity and decreased symptoms of overactive bladder.